Google Übersetzer
Precision Biosciences Inc
About
Precision Biosciences Inc (NASDAQ:DTIL) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study
Apr 28 2026
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
Apr 22 2026
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
Apr 15 2026
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Apr 8 2026
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Recent Videos
Precision BioSciences PBGENE-DMD and FUNCTION-DMD Investor Update | March 17, 2026
Mar 18, 2026
Precision Reports Fourth Quarter and Fiscal Year 2025 Financial Results & Provides Business Update
Mar 13, 2026
Precision Bio-Tech & Medical Packaging Solutions
Jan 31, 2026
Precision Bio-Equipment
Jan 10, 2026
Financials
Revenue
$34.26 M
Market Cap
$170.56 M
EPS
-3.63